Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04150900
Title 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Maryland, Baltimore
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.